Vital Farms (VITL) promoted a smooth ERP rollout and rising guidance. A lawsuit now alleges the company concealed known risks that later disrupted shipments, slowed production, and hit retail shelf space.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shareholders who purchased Vital Farms stock during a nine-month window are now at the center of a federal securities lawsuit, alleging the company concealed known risks tied to a major technology overhaul that ultimately disrupted shipments, cost the company critical retail shelf space, and caused the stock to fall more than 10%.
A securities class action complaint was filed on March 27, 2026, in the United States District Court for the Western District of Texas, Austin Division, against Vital Farms, Inc. (NASDAQ: VITL) and two of its top executives. The lawsuit covers investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026.
Investors who purchased VITL shares during this period may have legal options worth exploring.
What Vital Farms Does and Why It Matters to Investors
Vital Farms is described in the complaint as the leading U.S. brand of pasture-raised eggs and butter, positioning itself as an ethically minded food company focused on animal welfare and sustainable farming. The company is incorporated in Delaware, with its headquarters in Austin, Texas, and its shares trade on the Nasdaq stock market under the ticker symbol VITL.
The complaint notes that by the time the relevant events unfolded, the company had grown to become the second-largest U.S. egg brand by retail dollar sales. That prominence made any disruption in its supply chain or fulfillment capabilities particularly consequential, both for its retail partners and for shareholders relying on its stated financial guidance.
What Investors Allege Went Wrong
At the heart of the case is the allegation that Vital Farms was implementing a new enterprise resource planning system, commonly referred to as an ERP, and that while management was aware of the significant risks that implementation posed, the company’s public statements treated those risks as hypothetical rather than imminent. The complaint alleges that Defendants knew, or recklessly disregarded, that the ERP rollout would cause real disruptions in shipments and production, that this would result in lost retail shelf space, and that the company’s revenue guidance was therefore misleading.
The case alleges violations of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5, as well as control person liability under Section 20(a).
Investors who held VITL stock during the class period and suffered losses may want to speak with a securities attorney to understand their potential options.
What Management Said During the Class Period
The complaint quotes and paraphrases a series of management statements made between May and November of 2025 that allegedly painted a favorable picture of the ERP implementation. During a May 8, 2025, earnings call, Chief Financial Officer Thilo Wrede stated that the ERP launch date had been pushed from summer to early fall 2025 to ensure a flawless switchover, and that the timing adjustment did not add cost to the project. He described the ERP as fundamental to the operational improvements the company was planning.
On August 7, 2025, Wrede stated that the digital transformation initiative remained on track for an early fall 2025 switchover and simultaneously announced that the company was raising its full-year 2025 guidance from $740 million to $770 million. Then, on November 4, 2025, after the ERP went live on September 29, Wrede described the go-live as proceeding as planned and said that a brief slowdown in production during the first two weeks of the fourth quarter had always been part of the plan and had no impact on full-year guidance. He also stated that the business had quickly bounced back to pre-launch shipment levels and that guidance was raised a second time to $775 million.
How the Alleged Truth Came Out
The complaint identifies a single corrective disclosure event. On February 26, 2026, before markets opened, Vital Farms filed its annual report on Form 10-K for fiscal year 2025. The filing revealed that the company’s actual net revenue for the year was approximately $759.4 million, falling short of the $775 million guidance management had provided just three months earlier. The company also reported earnings per share of $0.35 against a market consensus of $0.39.
The 10-K acknowledged that in the fourth quarter of fiscal 2025, the company experienced temporary disruptions in order and fulfillment levels following the ERP launch. During the earnings call on the same day, Wrede stated that following several weeks of slow shipments after the ERP implementation in the lead-up to the peak holiday period, the company was still in the process of recapturing shelf space. In response to an analyst’s question, CEO Russel Diez-Canseco described a short-term dislocation and acknowledged that conversations with retailers had shifted from concerns about shipping reliability to discussions about long-term growth plans. On February 26, 2026, Vital Farms stock declined by $2.68 per share, or approximately 10.8%, to close at $22.11.
Why This Case May Be Significant for Shareholders
The complaint contends that investors who purchased VITL shares during the class period did so at prices that were allegedly artificially inflated because Defendants failed to disclose that the ERP implementation would cause real, known disruptions rather than the theoretical risks described in their SEC filings. The alleged gap between what management knew and what it disclosed to the public is central to the case.
If the allegations are borne out, investors who held Vital Farms stock between May 8, 2025, and February 26, 2026, and sold at a loss or held through the February 26 decline may have suffered damages tied directly to the corrective disclosure. The complaint also contends that the company’s repeatedly raised guidance during that period further insulated the stock price from accurately reflecting the operational risks at hand.
How the Lawsuit Is Structured Legally
The complaint brings two counts under the Securities Exchange Act of 1934. Count I is brought against all Defendants under Section 10(b) and Rule 10b-5, which prohibit making materially false or misleading statements in connection with the purchase or sale of securities. The plaintiff alleges that Defendants knowingly or recklessly issued false statements and omitted material information about the risks posed by the ERP implementation.
Count II is brought under Section 20(a) against the individual defendants, CEO Russel Diez-Canseco and CFO Thilo Wrede, alleging that as controlling persons of the company, they bear liability for the primary violations alleged in Count I.
Investors who purchased VITL shares during the class period and want to understand their legal rights are encouraged to consult with qualified securities counsel.
About Levi & Korsinsky, LLP
Levi & Korsinsky, LLP is a nationally recognized securities litigation firm representing investors in complex shareholder actions. The firm has extensive expertise and a team of over 70 employees to serve our clients. Attorney advertising. Prior results do not guarantee similar outcomes.
Disclaimer: This article is provided for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this article. Past results do not guarantee similar outcomes.